financetom
Business
financetom
/
Business
/
Capacity utilization at near 100%, says CEAT CFO Kumar Subbiah
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Capacity utilization at near 100%, says CEAT CFO Kumar Subbiah
Sep 29, 2020 5:02 AM

Capacity utilization at CEAT is nearly 100 percent, the company’s Chief Financial Officer, Kumar Subbiah said in interview with CNBCTV18.

Share Market Live

NSE

He said demand was slightly higher than pre-COVID levels.

Of the Rs 3500 crore earmarked for capex two years back, Rs 2200 has been spent, he said.

Subbiah said the company was unlikely to report losses for the quarter as the minimum revenue threshold had been crossed. He said rubber prices were at pre-COVID levels.

First Published:Sept 29, 2020 2:02 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe
Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe
Apr 17, 2026
06:53 AM EDT, 04/17/2026 (MT Newswires) -- Bruker's ( BRKR ) Bruker Microbiology & Infection Diagnostics division said Friday it has rolled out molecular diagnostics system MyGenius PRO in Europe. The new diagnostics system is based on polymerase chain reaction, developed to diagnose infectious diseases, according to the division. Bruker Microbiology said the MyGenius PRO system automates the complete workflow...
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
Apr 17, 2026
April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. Investors have been closely watching...
Lilly's Foundayo hits 1,390 prescriptions in debut week
Lilly's Foundayo hits 1,390 prescriptions in debut week
Apr 17, 2026
April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. ...
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Apr 17, 2026
06:54 AM EDT, 04/17/2026 (MT Newswires) -- Silgan's ( SLGN ) bid to take over German medical packaging maker Gerresheimer has been rejected, Reuters reported Friday, citing sources familiar with the matter. Talks between the two companies have concluded, the sources reportedly said. Silgan ( SLGN ) made a non-binding offer of 41 euros ($48.36) per share, Reuters previously reported....
Copyright 2023-2026 - www.financetom.com All Rights Reserved